Abstract
Functional MRI (fMRI) is one of the most common brain imaging modalities used for understanding brain organization and connectivity abnormalities associated with multiple sclerosis (MS). The fMRI signal is highly perturbed by head motion, which degrades data quality and influences all image-derived metrics. Numerous correction approaches have been proposed over the years to overcome the problems induced by head motion, however, despite a few efforts, there are still current and persistent controversies regarding the best correction strategy. The lack of a systematic comparison between different correction approaches motivates the search for optimal correction models, particularly in studies with clinical populations prone to characterize by higher motion. Moreover, motion correction strategies gain more relevance in task-based designs, which are less explored compared to resting-state and may have a crucial role in describing the functioning of the brain and highlighting specific connectivity changes.
We acquired fMRI data from a group of patients with early MS and matched healthy controls (HC) during performance of a visual task, characterized motion in both groups, and compared the most used motion correction methods. We compared task-activation metrics obtained from models without motion correction, models containing 6 or 24 motion parameters (MPs) as nuisance regressors, models containing 6 or 24 MPs and motion outliers detected with FD or DVARS as nuisance regressors (scrubbing) and models with 6 or 24 MPs where motion outliers were corrected through volume interpolation. To our knowledge, volume interpolation is a frequently used approach but was never compared with other existent methods.
Our results showed that there were no differences in motion between groups, suggesting that recently diagnosed MS patients do not present problematic motion. In general, models with 6 MPs present higher Z-scores than models with 24 MPs, suggesting the 6 MPs as the best trade-off between motion correction and preservation of valuable information. However, correction approaches differ between groups, regarding the combination of MPs with correction of motion outliers. Models with 6 MPs and outliers’ volume interpolation or scrubbing with FD presented higher Z-scores in the MS group, while models with 6 MPs and scrubbing with DVARS or volume interpolation were the best combinations for the HC group. Differences between groups in motion correction strategies draw attention to the intrinsic impact of MS on fMRI analyses, which should be carefully addressed.
This work paves the way towards finding an optimal motion correction strategy, which is required to improve the accuracy of fMRI analyses, crucially in clinical studies in MS and other patient populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants funded by Fundacao para a Ciencia e Tecnologia, UID/4950/2020 and PTDC/MEC-NEU/31973/2017. FCT also funded an individual contract to JVD (CEECIND/00581/2017) and an individual doctoral grant to JFS (2021.05349.BD).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee of the Faculty of Medicine of the University of Coimbra (ref. CE-047/2018) and the Ethics Committee of the Coimbra Hospital University Center (ref. CHUC-048-19) and was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent to participate in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.